Standing out in the field of IgY Immunotechnology

  • Home
    Home A full collection of all the Research Archive entries.
  • Years
    Years Sort entries by year.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Archives
    Archives Contains a list of research entries that were created previously.

Cloning, expression and antiviral activity of IFNγ from the Australian fruit bat, Pteropus alecto*

Posted by on in 2012
  • Font size: Larger Smaller
  • Hits: 3347
  • Print
Janardhana VTachedjian MCrameri GCowled CWang LFBaker ML. 2012. Dev Comp Immunol.  36:610-8. Epub 2011 Nov 7.

CSIRO Livestock Industries, Australian Animal Health Laboratory, P.O. Bag 24, Geelong, VIC 3220, Australia.

Abstract

Bats are natural reservoir hosts to a variety of viruses, many of which cause morbidity and mortality in other mammals. Currently there is a paucity of information regarding the nature of the immune response to viral infections in bats, partly due to a lack of appropriate bat specific reagents. IFNγ plays a key role in controlling viral replication and coordinating a response for long term control of viral infection. Here we describe the cloning and expression of IFNγ from the Australian flying fox, Pteropus alecto and the generation of mouse monoclonal and chicken egg yolk antibodies specific to bat IFNγ. Our results demonstrate that P. alecto IFNγ is conserved with IFNγ from other species and is induced in bat splenocytes following stimulation with T cell mitogens. P. alecto IFNγ has antiviral activity on Semliki forest virus in cell lines from P. alecto and the microbat, Tadarida brasiliensis. Additionally recombinant bat IFNγ was able to mitigate Hendra virus infection in P. alecto cells. These results provide the first evidence for an antiviral role for bat IFNγin vitro in addition to the application of important immunological reagents for further studies of bat antiviral immunity.

Crown Copyright © 2011. Published by Elsevier Ltd. All rights reserved.

*Note: The chicken IgY used in this publication was purified using the Eggspress IgY purification kit manufactured by Gallus Immunotech Inc.

Last modified on